Furthermore, C‐06 disrupts the interaction between PLG and ENO1, inhibits the PI3K‐AKT signaling pathway and the process of Epithelial‐Mesenchymal Transition (EMT), thereby attenuating the invasiveness of BL cells. The gene discussed is AKT1; the disease is Burkitt lymphoma.